- Home
- OST vs LEXX Comparison
OST vs LEXX Comparison
Compare OST & LEXX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OST
- LEXX
- Stock Information
- Founded
- OST 2010
- LEXX 2004
- Country
- OST China
- LEXX Canada
- Employees
- OST N/A
- LEXX N/A
- Industry
- OST Industrial Machinery/Components
- LEXX Biotechnology: Pharmaceutical Preparations
- Sector
- OST Technology
- LEXX Health Care
- Exchange
- OST Nasdaq
- LEXX Nasdaq
- Market Cap
- OST 15.7M
- LEXX 16.5M
- IPO Year
- OST 2022
- LEXX N/A
- Fundamental
- Price
- OST $1.70
- LEXX $1.21
- Analyst Decision
- OST
- LEXX Strong Buy
- Analyst Count
- OST 0
- LEXX 1
- Target Price
- OST N/A
- LEXX $4.00
- AVG Volume (30 Days)
- OST 97.5K
- LEXX 199.9K
- Earning Date
- OST 09-30-2025
- LEXX 07-14-2025
- Dividend Yield
- OST N/A
- LEXX N/A
- EPS Growth
- OST N/A
- LEXX N/A
- EPS
- OST N/A
- LEXX N/A
- Revenue
- OST $38,333,251.00
- LEXX $615,923.00
- Revenue This Year
- OST N/A
- LEXX $46.98
- Revenue Next Year
- OST N/A
- LEXX $17.26
- P/E Ratio
- OST N/A
- LEXX N/A
- Revenue Growth
- OST 0.34
- LEXX 49.85
- 52 Week Low
- OST $1.35
- LEXX $0.77
- 52 Week High
- OST $235.00
- LEXX $3.41
- Technical
- Relative Strength Index (RSI)
- OST 28.07
- LEXX 60.29
- Support Level
- OST $1.67
- LEXX $0.98
- Resistance Level
- OST $1.90
- LEXX $1.34
- Average True Range (ATR)
- OST 0.15
- LEXX 0.11
- MACD
- OST 0.92
- LEXX 0.04
- Stochastic Oscillator
- OST 42.48
- LEXX 55.77
About OST Ostin Technology Group Co. Ltd.
Ostin Technology Group Co Ltd is a supplier of display modules and polarizers in China. It designs, develops, and manufactures TFT-LCD modules in a wide range of sizes and customized sizes according to the specifications of its customers. Its display modules are mainly used in consumer electronics, commercial LCD displays, and automotive displays. The company also manufactures polarizers used in the TFT-LCD display modules and is in the process of developing polarizers for the OLED display panel. Geographically, the company generates revenue from Hong Kong, Taiwan, and Mainland China which is its key revenue generating market.
About LEXX Lexaria Bioscience Corp.
Lexaria Bioscience Corp's patented drug delivery technology, DehydraTECH improves the way active pharmaceutical ingredients enter the bloodstream by promoting more effective oral delivery. DehydraTECH can increase bio-absorption with cannabinoids and nicotine by 5-10x and, in some instances with cannabinoids by as much as 27x compared to standard industry formulations, reduce the time of onset from 1-2 hours to minutes, and mask unwanted tastes. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood-brain barrier. The company has four reportable segments: Intellectual Property Licensing which generates maximum revenue, B2B Production, Research and Development, and Corporate. Geographically, it derives revenue from the United States and Canada.